Washington, D.C. +1 202 261 3339
This month several U.S. senators introduced the Preserve Access to Affordable Generics Act. The bill would expand Federal Trade Commission powers and alter the legal test governing drug patent settlements. See Preserve Access to Affordable Generics Act, S. 214, 113th Cong., 1st Sess. (2013). This bill is the most recent iteration of such legislation, and, aside from updated data, it mirrors bills introduced in 2009 and 2011. See S. 27, 112th Cong., 1st Sess. (2011); S. 369, 111th Cong., 1st Sess. (2009).
To keep reading, download the full article.